Good evening, this is Markets Desk with your end-of-day briefing.
Semiconductor investors are being warned to watch the currency markets closely, as foreign exchange flows may be signaling further weakness ahead in chip stocks. Analysts point to cross-asset dynamics suggesting institutional money could be rotating out of the sector, and the charts are not offering much comfort for those holding long positions.
Shifting to consumer equities, the debate over Chewy versus Coupang is sharpening heading into two thousand twenty six. Chewy is pushing beyond its digital roots with its acquisition of Modern Animal, expanding into physical veterinary clinics — a move designed to deepen customer loyalty and build recurring revenue streams that pure e-commerce alone cannot sustain.
And on the pharmaceutical side, Pfizer remains under significant pressure, with the stock down sharply as investors weigh concerns about its longer-term pipeline and revenue durability following the wind-down of its COVID-era tailwinds. The question now is whether the current valuation represents a floor or simply a pause before further deterioration.
That's the tape. Markets Desk, signing off the floor.
